DK1011674T3 - Transdermalt terapeutisk system indeholdende det aktive stof af scopolaminbase - Google Patents

Transdermalt terapeutisk system indeholdende det aktive stof af scopolaminbase

Info

Publication number
DK1011674T3
DK1011674T3 DK98946364T DK98946364T DK1011674T3 DK 1011674 T3 DK1011674 T3 DK 1011674T3 DK 98946364 T DK98946364 T DK 98946364T DK 98946364 T DK98946364 T DK 98946364T DK 1011674 T3 DK1011674 T3 DK 1011674T3
Authority
DK
Denmark
Prior art keywords
active substance
layer
transdermal therapeutic
therapeutic system
system containing
Prior art date
Application number
DK98946364T
Other languages
Danish (da)
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1011674T3 publication Critical patent/DK1011674T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DK98946364T 1997-09-04 1998-08-18 Transdermalt terapeutisk system indeholdende det aktive stof af scopolaminbase DK1011674T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19738643A DE19738643C2 (de) 1997-09-04 1997-09-04 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
PCT/EP1998/005224 WO1999011265A1 (de) 1997-09-04 1998-08-18 Transdermales therapeutisches system mit dem wirkstoff scopolaminbase

Publications (1)

Publication Number Publication Date
DK1011674T3 true DK1011674T3 (da) 2002-07-08

Family

ID=7841162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98946364T DK1011674T3 (da) 1997-09-04 1998-08-18 Transdermalt terapeutisk system indeholdende det aktive stof af scopolaminbase

Country Status (22)

Country Link
US (1) US6537571B1 (ja)
EP (1) EP1011674B1 (ja)
JP (1) JP3834202B2 (ja)
KR (1) KR100549846B1 (ja)
AT (1) ATE214606T1 (ja)
AU (1) AU738009B2 (ja)
CA (1) CA2300339C (ja)
DE (2) DE19738643C2 (ja)
DK (1) DK1011674T3 (ja)
ES (1) ES2174492T3 (ja)
HK (1) HK1032194A1 (ja)
HU (1) HUP0003480A3 (ja)
ID (1) ID24266A (ja)
IL (1) IL134418A (ja)
NO (1) NO20000894D0 (ja)
NZ (1) NZ502873A (ja)
PL (1) PL339226A1 (ja)
PT (1) PT1011674E (ja)
SK (1) SK3052000A3 (ja)
TR (1) TR200000407T2 (ja)
WO (1) WO1999011265A1 (ja)
ZA (1) ZA988052B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013957A1 (en) * 2003-07-15 2005-01-20 Boris Leschinsky Disposable medical article with multiple adhesives for skin attachment
DE102004020463A1 (de) * 2004-04-26 2005-11-10 Grünenthal GmbH Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
EP1998756A2 (en) * 2006-02-27 2008-12-10 Noven Pharmaceuticals, Inc. Compositions and methods for delivery of amino-functional drugs
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
KR101572721B1 (ko) 2013-10-14 2015-11-27 주식회사 엘지생활건강 히오신을 유효 성분으로 함유하는 피부 건조증 또는 피부 장벽 기능 개선용 조성물
US20180049999A1 (en) * 2015-04-14 2018-02-22 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
CA3061284A1 (en) * 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing scopolamine and silicone acrylic hybrid polymer
DE102018118507A1 (de) * 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35474A (en) * 1862-06-03 Improved rocket-harpoon
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
DE69427391T2 (de) * 1993-09-30 2001-10-31 Takiron Co. Ltd., Osaka Perkutan absorbierbare zubereitung
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
DE4438989C2 (de) * 1994-09-16 1999-02-25 Lohmann Therapie Syst Lts Scopolaminpflaster
DE69616370T2 (de) * 1995-12-01 2002-07-11 Alza Corp., Palo Alto Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix

Also Published As

Publication number Publication date
HK1032194A1 (en) 2001-07-13
ES2174492T3 (es) 2002-11-01
AU738009B2 (en) 2001-09-06
HUP0003480A3 (en) 2001-03-28
IL134418A0 (en) 2001-04-30
ZA988052B (en) 1999-03-05
JP3834202B2 (ja) 2006-10-18
NZ502873A (en) 2001-07-27
TR200000407T2 (tr) 2000-08-21
SK3052000A3 (en) 2000-12-11
CA2300339A1 (en) 1999-03-11
KR100549846B1 (ko) 2006-02-06
ATE214606T1 (de) 2002-04-15
PT1011674E (pt) 2002-08-30
AU9343498A (en) 1999-03-22
US6537571B1 (en) 2003-03-25
EP1011674B1 (de) 2002-03-20
CA2300339C (en) 2007-07-17
ID24266A (id) 2000-07-13
EP1011674A1 (de) 2000-06-28
WO1999011265A1 (de) 1999-03-11
JP2001514226A (ja) 2001-09-11
NO20000894L (no) 2000-02-23
KR20010023647A (ko) 2001-03-26
IL134418A (en) 2004-02-19
DE59803454D1 (de) 2002-04-25
DE19738643A1 (de) 1999-03-11
HUP0003480A2 (hu) 2001-02-28
PL339226A1 (en) 2000-12-04
DE19738643C2 (de) 2001-10-04
NO20000894D0 (no) 2000-02-23

Similar Documents

Publication Publication Date Title
IE59729B1 (en) Therapeutic system, process for its production and its use
NO20001003D0 (no) Transdermalt terapeutisk system omfattende et trykksensitivt adhesivt reservoarsjikt og et unidireksjonalt elastisk dekksjikt
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
NO972565D0 (no) Estradiolholdig plaster
DK1011674T3 (da) Transdermalt terapeutisk system indeholdende det aktive stof af scopolaminbase
DK0659081T3 (da) Dexpanthenol-holdigt plaster til transdermal applikation af steroidhormoner
CA2335582A1 (en) Transdermal therapeutic system containing hormones and crystallization inhibitors
CA2490573A1 (en) Improved transdermal delivery system
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
CA2403949A1 (en) Transdermal therapeutic system for the delivery of lerisetron
DK1251853T3 (da) Transdermalt terapeutisk system til indgivelse af zaleplon
FI953532A0 (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja sen käyttö
RU2001101443A (ru) Чрескожная терапевтическая система, содержащая гормоны и ингибиторы кристаллизации
HRP920858A2 (en) Flat therapeutic system